Intersect ENT (XENT)
(Delayed Data from NSDQ)
$28.24 USD
0.00 (0.00%)
Updated May 12, 2022 04:00 PM ET
NA Value
NA Growth NA Momentum NA VGMPrice, Consensus and EPS Surprise
XENT 28.24 0.00(0.00%)
Will XENT be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for XENT based on the 1-3 month trading system that nearly triples the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for XENT
Sientra (SIEN) Reports Q1 Loss, Tops Revenue Estimates
Intersect ENT (XENT) Q1 Earnings & Revenues Miss Estimates
XENT: What are Zacks experts saying now?
Zacks Private Portfolio Services
DexCom (DXCM) Misses Q1 Earnings Estimates
SeaSpine Holdings (SPNE) Reports Q4 Loss, Tops Revenue Estimates
OrthoPediatrics (KIDS) Reports Q4 Loss, Tops Revenue Estimates
Other News for XENT
No Record found.